OMER
OMER
NASDAQ · Pharmaceuticals

Omeros Corp

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$11.05
+0.05 (+0.45%)
Analyst Consensus
Buy
11
Analysts
Moderate
Coverage
Buy 8 73%
Hold 3 27%
Sell 0 0%
Price Target
Analyst Price Target +489.8% upside
Low Target $47.12
Average Target $65.17
High Target $100.64
Current Price $11.05
Current
$11.05
Target
$65.17
$47.12 $65.17 avg $100.64
Scenario Analysis
Bear Case
$47.12
326.4%
Low target
Base Case
$65.17
+489.8%
Avg target
Bull Case
$100.64
+810.8%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$17.65
-37.4% from high
52-Week Low
$2.95
+274.6% from low
Target vs 52W High
$65.17
+269.2% vs high
Next Earnings Report
Mar 30, 2026 · After Market Close
3d
until earnings
EPS Est: $-0.58
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +809.8%